Table 8.
Conventional therapeutics for OA.
Category | Drugs | Mechanism of Action | Analgesic Action Level |
---|---|---|---|
NSAIDs | Aspirin, naproxen, ibuprofen, diclofenac, celecoxib, piroxicam, indomethacin, meloxicam, ketoprofen, sulindac, diflunisal, nabumetone, oxaprozin, tolmetin, salsalate, etodolac, fenoprofen, flurbiprofen, ketorolac, meclofenamate, mefenamic acid, etoricoxib, and rofecoxib. | inhibit COX enzymes leading to decreased prostaglandin synthesis. increasing serotonin in central sites |
Peripheral and central effects |
Analgesics | Acetaminophen | Peripheral: COX1 and 2 inhibition Central: descending serotonergic neuronal pathways, inhibition of L-arginine/NO pathway, stimulation of endocannabinoid system, and anti-nociception mechanisms |
Peripheral and central effects |
Duloxetine | Serotonin and nonrepinephrine reuptake inhibitor | Central effects | |
Opioids and opioid receptor ligands | Morphine, codeine, acetaminophen with codeine, fentanyl, hydrocodone, acetaminophen with hydrocodone, hydromorphone, meperidine, oxycodone | Activate opioids receptors to hyperpolarizes sensory neurons and attenuate nerve hyperexcitability | Peripheral and central effects |
Corticosteroids | Prednisone, betamethasone, cortisone, dexamethasone, hydrocortisone, methylprednisolone, prednisolone, triamcinolone acetonide | Immunosuppressive and anti-inflammatory by interrupting the inflammatory cascade | Peripheral |
Joint modifying treatments | Chondroitin and glucosamine | Increase proteoglycan synthesis in articular cartilage | Peripheral/local |
Hyaluronic acid | Enhance chondrocyte synthesis of endogenous hyaluronic acid and proteoglycans | Peripheral/local |